Topics

Videos

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, shares how the imposed/pending trade tariffs impact pharma manufacturers.

Properly Preparing for Tariffs and Other Supply Chain Obstacles

A founding partner with Curatio Scientia Advisors.

A founding partner with Curatio Scientia Advisor.

Articles

A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.

Transforming Specialty Pharmacy Engagement

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld value & access advisor for Schoonveld Advisory and author of The Price of Global Health, previews his upcoming February column.

The Rundown on Rebates

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, value & access advisor for Schoonveld Advisory and author of The Price of Global Health, comments on the future implications of the latest CMS drug price negotiations.

What Round II of Medicare Part D Drug Prices Signify for the Pharma Industry

Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial intelligence and predictive forecasting. 

The Digital Transformation Reshaping Hospitals and Medication Management

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today. 

Navigating Access and Reimbursement Through Uncertainty 

How will supply chains in the space continue to develop?

Forecasting the 2025 Healthcare Logistics Space

Why well-organized documentation is critical at every stage of the process.

Technically Speaking: Quality Documentation is One of the Best Ways to Boost Performance

In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.

Understanding the FDA's Exemption for DSCSA Compliance

CEO of Medigi, and a member of Pharmaceutical Commerce’s Editorial Advisory Board.

Tips for pharmacies with the reimbursement blues.

Opinion